hims & hers fda warning letter compounded semaglutide 2025 ๐จ Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Compounded "semaglutide" is not FDA-approved
Description
Cardiovasc Diabetol 16(1):143 Ceravolo R, Maio R, Pujia A, Sciacqua A, Ventura G, Costa MC et al (2003) Pulse pressure and endothelial dysfunction in never-treated hypertensive patients
Certain individuals are at a significantly higher risk of adverse effects and should exercise extreme caution or, in many cases, outright avoid this combination
12 mg remains the highest-efficacy dose, but it carries a meaningfully worse GI burden and a correspondingly higher dropout risk

doi:10.1111/dom.16376 These statements have not been evaluated by the Food and Drug Administration

A doctor's letter is strongly recommended for international travel and essential for some destinations